Lobie, Peter E.

An Automated Organoid Platform with Inter-organoid Homogeneity and Inter-patient Heterogeneity

Jiang, S., Zhao, H., Zhang, W., Wang, J., Liu, Y., Cao, Y., Zheng, H., Hu, Z., Wang, S., Zhu, Y., et al. (2020) · Cell Reports Medicine

3D Printing in Biomedical ResearchCancer Cells and Metastasis

Cited by 188

Bad phosphorylation as a target of inhibition in oncology

Bui, N.-L.-C., Pandey, V., Zhu, T., Ma, L., Basappa, & Lobie, P. E. (2018) · Cancer Letters

Cell death mechanisms and regulationCancer-related Molecular Pathways

Cited by 86

Mitochondria: The metabolic switch of cellular oncogenic transformation

Tan, Y. Q., Zhang, X., Zhang, S., Zhu, T., Garg, M., Lobie, P. E., & Pandey, V. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer

Cancer, Hypoxia, and MetabolismMitochondrial Function and Pathology

Cited by 75

Discovery of a small-molecule inhibitor of specific serine residue BAD phosphorylation

Pandey, V., Wang, B., Mohan, C. D., Raquib, A. R., Rangappa, S., Srinivasa, V., Fuchs, J. E., Girish, K. S., Zhu, T., Bender, A., et al. (2018) · Proceedings of the National Academy of Sciences

Cell death mechanisms and regulationPI3K/AKT/mTOR signaling in cancer

Cited by 59

Pharmacological inhibition of BAD Ser99 phosphorylation enhances the efficacy of cisplatin in ovarian cancer by inhibition of cancer stem cell-like behavior

Wang, Y., Chiou, Y.-S., Chong, Q.-Y., Zhang, M., Rangappa, K. S., Ma, L., Zhu, T., Kumar, A. P., Huang, R. Y.-J., Pandey, V., et al. (2020) · ACS Pharmacology & Translational Science

Ovarian cancer diagnosis and treatmentCell death mechanisms and regulation

Cited by 20

Combining Mitomycin C with inhibition of BAD phosphorylation enhances apoptotic cell death in advanced cervical cancer

Wang, L., Zhang, X., Chen, S., Ye, Q., Basappa, B., Zhu, T., Lobie, P. E., & Pandey, V. (2024) · Translational Oncology

Cell death mechanisms and regulationCancer-related Molecular Pathways

Cited by 8